Trends in Psychiatry and Psychotherapy
https://trends.org.br/article/doi/10.1590/2237-6089-2016-0074
Trends in Psychiatry and Psychotherapy
Brief Communication

Cell therapy in the treatment of bipolar mania in an animal model: a proof of concept study

Terapia celular no tratamento do transtorno bipolar: estudo piloto em um modelo animal de mania

Bruna M. Ascoli; Rafael Colombo; Luiza P. Géa; Paula B. Terraciano; Sabrina B. Pizzato; Fernanda S. de Oliveira; Elizabeth Cirne-Lima; Flávio Kapczinski; Adriane R. Rosa

http://dx.doi.org/10.1590/2237-6089-2016-0074 Trends Psychiatry Psychother, vol.39, n3, p.196-201, 2017
PDF
SciELO
Downloads: 0
Views: 533

Abstract

Abstract Introduction The rationale of mesenchymal stem cells (MSCs) as a novel therapeutic approach in certain neurodegenerative diseases is based on their ability to promote neurogenesis. Hippocampal atrophy has been related to bipolar disorder (BD) in preclinical, imaging and postmortem studies. Therefore, the development of new strategies to stimulate the neurogenesis process in BD is crucial. Objectives To investigate the behavioral and neurochemical changes induced by transplantation of MSCs in a model of mania-like behavior induced by lisdexamfetamine dimesylate (LDX). Methods Wistar rats (n=65) received one oral daily dose of LDX (10 mg/kg) or saline for 14 days. On the 8th day of treatment, the animals additionally received intrahippocampal saline or MSC (1 µL containing 25,000 cells) or lithium (47.5 mg/kg) as an internal experimental control. Two hours after the last administration, behavioral and neurochemical analyses were performed. Results LDX-treated rats had increased locomotor activity compared to saline-saline rats (p=0.004), and lithium reversed LDX-related hyperactive behavior (p<0.001). In contrast, the administration of MSCs did not change hyperlocomotion, indicating no effects of this treatment on LDX-treated rats (p=0.979). We did not find differences between groups in BDNF levels (p>0.05) in the hippocampus of rats. Conclusion Even though these results suggest that a single intrahippocampal injection of MSCs was not helpful to treat hyperactivity induced by LDX and neither influenced BDNF secretion, we cannot rule out the possible therapeutic effects of MSCs. Further research is required to determine direct effects of LDX on brain structures as well as in other pathophysiological targets related to BD.

Keywords

Mesenchymal stem cells, cellular therapy, bipolar disorder, mania, neurogenesis, hippocampus

Resumo

Resumo Introdução Células-tronco mesenquimais (CTMs) têm emergido como um promissor tratamento em diversas doenças neurodegenerativas devido a sua plasticidade e capacidade de regenerar tecidos. Estudos pré-clínicos, clínicos e de neuroimagem têm demonstrado a presença de atrofia hipocampal no transtorno bipolar (TB). Portanto, o desenvolvimento de tratamentos capazes de regenerar tecido lesado e estimular a neurogênese poderia ser útil. Objetivos Investigar mudanças comportamentais e neuroquímicas induzidas pelo transplante de CTMs no hipocampo de ratos em um modelo animal de mania induzido por dimesilato de lisdexanfetamina (LDX). Métodos Ratos Wistar (n=65) receberam LDX (10 mg/kg) ou solução salina por via oral durante 14 dias. No oitavo dia, os animais foram transplantados com injeção de CTMs ou solução salina (1 µL contendo 25.000 células) ou lítio (47,5 mg/kg) como controle interno do experimento. Duas horas após a última dose, foram realizadas análises comportamentais e neuroquímicas. Resultados Animais que receberam LDX tiveram um aumento da atividade locomotora comparados ao grupo que recebeu solução salina (p=0,004); já o lítio reverteu a hiperatividade locomotora desses animais (p<0,001). Os animais que receberam CTMs não apresentaram alterações no comportamento, indicando ausência de efeitos sobre hiperatividade locomotora. Os níveis de BDNF hipocampais não diferiram entre os grupos (p>0.05). Conclusão Não foi possível demonstrar efeitos neuroprotetores das CTMs, administradas em dose única, em um modelo animal de mania induzido por LDX. No entanto, não se pode descartar os possíveis efeitos terapêuticos das CTMs. Mais estudos são necessários para determinar os efeitos das CTMs em estruturas cerebrais e outros alvos fisiopatológicos relacionados ao TB.

Palavras-chave

Células mesenquimais, terapia celular, transtorno bipolar, mania, neurogênese, hipocampo

References

Post RM, Fleming J, Kapczinski F. Neurobiological correlates of illness progression in the recurrent affective disorders. J Psychiatr Res. 2012;46:561-73.

Kim HW, Rapoport SI, Rao JS. Altered expression of apoptotic factors and synaptic markers in postmortem brain from bipolar disorder patients. Neurobiol Dis. 2010;37:596-603.

Coquery N, Blesch N, Stroh A, Fernández-Klettf F, Klein J, Winter C, Priller J. Intrahippocampal transplantation of mesenchymal stromal cells promotes neuroplasticity. Cytotherapy. 2012;14:1041-53.

Colpo GD, Ascoli BM, Wollenhaupt-Aguiar B, Pfaffenseller B, Silva EG, Cirne-Lima EO. Mesenchymal stem cells for the treatment of neurodegenerative and psychiatric disorders. An Acad Bras Cienc. 2015;87:1435-49.

Kim N, Cho S. New Strategies for overcoming limitations of mesenchymal stem cell-based immune modulation. Int J Stem Cells. 2015;8:54-68.

Tfilin M, Sudai E, Merenlender A, Gispan I, Yadid G, Turgeman G. Mesenchymal stem cells increase hippocampal neurogenesis and counteract depressive-like behavior. Mol Psychiatry. 2010;15:1164-75.

Quigley SJ, Scanlon C, Kilmartin L, Emsell L, Langan C, Hallahan B. Volume and shape analysis of subcortical brain structures and ventricles in euthymic bipolar I disorder. Psychiatry Res. 2015;233:324-30.

Harrisberger F, Smieskova R, Schmidt A, Lenz C, Walter A, Wittfeld K. BDNF Val66Met polymorphism and hippocampal volume in neuropsychiatric disorders: A systematic review and meta-analysis. Neurosci Biobehav Rev. 2015;55:107-18.

Cunha AB, Frey BN, Andreazza AC, Goi JD, Rosa AR, Gonçalves CA. Serum brain-derived neurotrophic factor is decreased in bipolar disorder during depressive and manic episodes. Neurosci Lett. 2006;398:215-9.

Hajek T, Bauer M, Simhandl C, Rybakowski J, O’Donovan C, Pfennig A. Neuroprotective effect of lithium on hippocampal volumes in bipolar disorder independent of long-term treatment response. Psychol Med. 2014;44:507-17.

Guide for the care and use of laboratory animals. 2011.

Schneider N, Gonçales FC, Pinto FO, Lopez PLC, Araújo AB, Pfaffenseller B. Dexamethasone and azathioprine promote cytoskeletal changes and affect mesenchymal stem cell migratory behavior. Plos One. 2015;10:1-20.

Macêdo DS, Lucena DF de, Queiroz AI, Cordeiro RC, Araújo MM, Sousa FC. Effects of lithium on oxidative stress and behavioral alterations induced by lisdexamfetamine dimesylate: relevance as an animal model of mania. Prog Neuropsychopharmacol Biol Psychiatry. 2013;43:230-7.

Paxinos G, Watson C. The rat brain in stereotaxic coordinates: hard cover edition. 2006.

Dezawa M, Kanno H, Hoshino M, Cho H, Matsumoto N, Itokazu Y. Specific induction of neuronal cells from bone marrow stromal cells and application for autologous transplantation. J Clin Investig. 2004;113:1701-10.

Kim YJ, Park HJ, Lee G, Bang OY, Ahn YH, Joe E. Neuroprotective effects of human mesenchymal stem cells on dopaminergic neurons through anti-inflammatory action. Glia. 2009;57:13-23.

Morita T, Sasaki M, Kataoka-Sasaki Y, Nakazaki M, Nagahama H, Oka S. Intravenous infusion of mesenchymal stem cells promotes functional recovery in a model of chronic spinal cord injury. Neuroscience. 2016;335:221-31.

Darkazalli A, Ismail AA, Abad N, Grant SC, Levenson CW. Use of human mesenchymal stem cell treatment to prevent anhedonia in a rat model of traumatic brain injury. Restor Neurol Neurosci. 2016;34:433-41.

Danielyan L, Beer-Hammer S, Stolzing A, Schäfer R, Siegel G, Fabian C. Intranasal delivery of bone marrow-derived tem cells, macrophages, and microglia to the brain in mouse models of Alzheimer’s and Parkinson’s disease. Cell Transplant. 2014;23:S123-39.

Strakowski SM, Adler CM, Almeida J, Altshuler LL, Blumberg HP, Chang KD. The functional neuroanatomy of bipolar disorder: a consensus model. Bipolar Disord. 2012;14:313-25.

Janowski M, Engels C, Gorelik M, Lyczek A, Bernard S, Bulte JW. Survival of neural progenitors allografted into the CNS of immunocompetent recipients is highly dependent on transplantation site. Cell Transplant. 2014;23:253-62.

Habisch HJ, Janowski M, Binder D, Kuzma-Kozakiewicz M, Widmann A, Habich A. Intrathecal application of neuroectodermally converted stem cells into a mouse model of ALS: limited intraparenchymal migration and survival narrows therapeutic effects. J Neural Transm. 2007;114:1395-406.

Sharma AN, Fries GR, Galvez JF, Valvassori SS, Soares JC, Carvalho AF. Modeling mania in preclinical settings: A comprehensive review. Prog Neuropsychopharmacol Biol Psychiatry. 2016;66:22-34.

6169d6fea95395584a2aecb3 trends Articles
Links & Downloads
2238-0019 (Electronic)
Trends Psychiatry Psychother ©2024 All rights reserved.

Trends Psychiatry Psychother

Share this page
Page Sections